NATIONAL MULTIPLE SCLEROSIS SOCIETY for NATIONAL MULTIPLE SCLEROSIS SOCIETY
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation Technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption -Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CALDER | — |
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Budget/Appropriations BUD
H.R. 2740- Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 oIncluded department of Defense Appropriations Act, 2019, support $16 million for the MSRP. Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $41.6 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $10 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget. H.R. 3055- Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 oSupporting $3.3 billion for the Food and Drug Administration. Supporting same funding levels in Senate for these programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Civil Rights/Civil Liberties CIV
N/A
Foreign entity interest: No foreign interests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Transportation TRA
N/A
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Medicare/Medicaid MMM
N/A
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CALDER | — |
| GRANT COUCH | — |
| JACOB GOODMAN | — |
Medical/Disease Research/Clinical Labs MED
N/A
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.